Over the last few years, the orexin system has progressed to being a promising target for new medications and therapeutical approaches, along with physical activity, such as to resist obesity, increase SPA and energy expenditure, treat addiction, and prevent and treat aging-related cognitive decline. The gene discussed is HCRT; the disease is obesity due to melanocortin 4 receptor deficiency.